SANA Sana Biotechnology Inc
Price (delayed)
$4.53
Market cap
$1.01B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.15
Enterprise value
$967.54M
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and
Highlights
The EPS is up by 39% year-on-year and by 25% since the previous quarter
The net income is up by 32% year-on-year and by 21% since the previous quarter
SANA's quick ratio has soared by 70% YoY but it is down by 15% from the previous quarter
The equity has contracted by 9% from the previous quarter and by 4.3% YoY
Key stats
What are the main financial stats of SANA
Market
Valuations
Earnings
Shares outstanding
222.47M
Market cap
$1.01B
Enterprise value
$967.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.95
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$244.9M
EBITDA
-$209.6M
Free cash flow
-$284.86M
Per share
Balance sheet
Liquidity
EPS
-$1.15
Free cash flow per share
-$1.22
Book value per share
$1.53
Revenue per share
$0
TBVPS
$1.79
Total assets
$618.67M
Total liabilities
$279.02M
Debt
$98.56M
Equity
$339.65M
Working capital
$212.76M
Debt to equity
0.29
Current ratio
5.2
Quick ratio
5.04
Net debt/EBITDA
0.19
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-39.2%
Return on equity
-71.6%
Return on invested capital
-79.1%
Return on capital employed
-43.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SANA stock price
How has the Sana Biotechnology stock price performed over time
Intraday
-9.22%
1 week
-16.27%
1 month
-7.36%
1 year
-20.39%
YTD
11.03%
QTD
-17.03%
Financial performance
How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$252.9M
Net income
-$244.9M
Gross margin
N/A
Net margin
N/A
The net income is up by 32% year-on-year and by 21% since the previous quarter
The operating income has grown by 31% YoY and by 21% from the previous quarter
Growth
What is Sana Biotechnology's growth rate over time
Valuation
What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
2.95
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 39% year-on-year and by 25% since the previous quarter
SANA's P/B is 10% below its last 4 quarters average of 3.6
The equity has contracted by 9% from the previous quarter and by 4.3% YoY
Efficiency
How efficient is Sana Biotechnology business performance
The company's return on invested capital rose by 21% QoQ and by 8% YoY
The return on equity has grown by 20% since the previous quarter and by 9% year-on-year
Sana Biotechnology's ROA has increased by 18% from the previous quarter and by 14% YoY
Dividends
What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SANA.
Financial health
How did Sana Biotechnology financials performed over time
The company's total assets is 122% higher than its total liabilities
The current ratio has soared by 72% YoY but it is down by 14% from the previous quarter
SANA's quick ratio has soared by 70% YoY but it is down by 15% from the previous quarter
SANA's debt is 71% smaller than its equity
SANA's debt is down by 13% year-on-year and by 7% since the previous quarter
The equity has contracted by 9% from the previous quarter and by 4.3% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.